Is Tilray stock going to $0?
The company isn’t in good financial shape, and there’s still plenty of risk with the stock.
This Canadian cannabis stock is a buy, analyst says
Research Capital analyst Andre Greg McLeish has reiterated a “Buy” rating and $3.50 price target on Cannara Biotech …
Should you sell your Aurora Cannabis stock?
Roth Capital Markets analyst Bill Kirk reiterated a “Neutral” rating on ACB and lowered his 12-month price target to C$5.00 from C$6.00 …
Should you buy, hold or sell ACB stock post Q3 earnings release?
Aurora Cannabis ACB recently reported its third-quarter results for fiscal 2026 (year ending March 2026). Both earnings and sales beat our consensus estimates. This Canada-based cannabis operator …
Aurora Cannabis Reports Increased Revenue And Free Cash Flow For Q3-2026
Aurora Cannabis Inc. Q3 results: revenue, free cash flow up as ACB exits propagation & targets higher-margin international medical cannabis. Click for this update.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Should you sell your Aurora Cannabis stock?
Roth Capital Markets analyst Bill Kirk reiterated a “Neutral” rating on ACB and lowered his 12-month price target to C$5.00 from C$6.00 …
Should you buy, hold or sell ACB stock post Q3 earnings release?
Aurora Cannabis ACB recently reported its third-quarter results for fiscal 2026 (year ending March 2026). Both earnings and sales beat our consensus estimates. This Canada-based cannabis operator …
Aurora Cannabis Reports Increased Revenue And Free Cash Flow For Q3-2026
Aurora Cannabis Inc. Q3 results: revenue, free cash flow up as ACB exits propagation & targets higher-margin international medical cannabis. Click for this update.
2 risky stocks that could send your $100,000 investment to $0
Cannabis stocks look risky because price wars, dilution, and regulation can turn one weak quarter into a long drawdown. The post 2 Risky Stocks That Could Send Your $100,000 Investment to $0 appeared …
2 Popular Stocks That Could Wipe Out a $100,000 Nest Egg
Aurora Cannabis (TSX:ACB) is one stock that could wipe out your nest egg. The post 2 Popular Stocks That Could Wipe Out a $100,000 Nest Egg appeared first on The Motley Fool Canada.
3 Reasons Why These 3 Cannabis Stocks Could Have a Magnificent 2026
The cannabis sector is one which many may have rightly described as a bubble seven or eight years ago. That’s because it was. Valuations in this sector got to obscene levels, with plenty of top …
Safe Harbor Expands Payments Solutions Portfolio to Help Cannabis Operators Cut Cash, Boost Stability
This expansion in payment options follows the recent launch of insurance and payroll services for Safe Harbor clients as part of the Company’s broader effort to build a full-service financial platform …
Canopy Growth Stock Gains As Trump Cannabis Order Reshapes Tax Rules
Canopy Growth shares are up following President Donald Trump’s recent executive order urging the Department of Justice to reschedule cannabis to Schedule 3.
Buy this cannabis stock, analyst says
Beacon Securities analyst Russell Stanley has maintained a “Buy” rating and C$5.00 price target on Curaleaf Holdings …
Recent Comments